Aurobindo Pharma Limited (AUROPHARMA.NS) NSE

Currency In INR

AD

Aurobindo Pharma Limited

Address

Galaxy, Plot No. 1

Hyderabad, TS 500032

India

Phone

91 40 6672 5000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

27707

First IPO Date

January 15, 1996

Key Executives

NameTitlePayYear Born
Makkapati SatakarniPresident of Biologics, Chief Executive Officer of Biologics, Vaccines and Peptid & Director800,0001981
Baddigam Adi ReddyCompliance Officer & Company Secretary4.76MN/A
Santhanam SubramanianChief Financial Officer21.06M1961
Kambam Nityananda ReddyVice Chairman & MD54.69M1958
Mettu Madan Mohan ReddyWhole-Time Director69.79M1960
Parveen Kumar LuthraChief Scientific Officer01971
K. Suresh KumarAssociate President of HR0N/A
S. Vijaya KumarPresident of Technical01966
Ilapakurty Chandra RaoSenior Vice President of Admin0N/A
Mula Surya Narayana MurthySenior Vice President of Accounts0N/A
AD

Description

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

AD